During
ischemia nitrite may be converted into
nitric oxide (NO) by reaction with
heme-carrying
proteins or
thiol-containing
enzymes. NO acts as a regulator of vasodilation and protector against oxidative stress-induced tissue
injuries. As a result of
ischemia-induced oxidative stress,
hypoxia and/or
acidosis bivalent
copper ions (Cu(2+)) can dissociate from their physiological
carrier proteins. Reduced by the body's own
antioxidants, the resultant Cu(1+) might represent an effective
reductant of
nitrite. Here we have evaluated in vitro
copper-dissociation from
copper/BSA (
bovine serum albumin) complexes under ischemic conditions. Furthermore, using physiological concentrations, we have characterized the capacity of
antioxidants and bivalent
copper ions to serve as Cu(1+)-agitated catalytic sites for
nitrite reduction and also the
biological responses of this mechanism in vitro. We found that as a consequence of an acidic milieu and/or oxidative stress the
copper-binding capacity of
serum albumin strongly declined, leading to significant dissociation of
copper ions into the ambient
solution. At physiologically relevant pH-values Cu(2+)
ions in combination with physiologically available
copper reductants (i.e., ascorbate,
glutathione, Fe(2+)) significantly enhanced
nitrite reduction and subsequent non-enzymatic NO generation under hypoxic but also normoxic conditions. Our data demonstrate for the first time that upon ischemic conditions
carrier protein-dissociated
copper ions combined with appropriate
reductants may serve as Cu(1+)-driven catalytic sites for
nitrite reduction, leading to the formation of biologically relevant NO formation. Thus, in addition to the action of
heme proteins,
copper-catalyzed non-enzymatic NO formation from
nitrite might represent a further physiologically relevant vasodilating and NO-dependent protective principle to ischemic stress.